GLP 1

When GLP-1s Change Patients’ Libido: What to Know

It’s not discussed as often as other side effects of GLP-1 receptor agonists, but one adverse effect is the drugs’ potential to interfere with patients’ libido, causing a dulling or dampening effect. Good news for patients, however, is that the issue can be mitigated. About 4% of Americans were taking GLP-1 receptor agonists in 2024 […]

When GLP-1s Change Patients’ Libido: What to Know Read More »

When GLP-1s Change Patients’ Libido: What to Know

Julie Peck September 23, 2025 It’s not discussed as often as other side effects of GLP-1 receptor agonists, but one adverse effect is the drugs’ potential to interfere with patients’ libido, causing a dulling or dampening effect. Good news for patients, however, is that the issue can be mitigated. About 4% of Americans were taking

When GLP-1s Change Patients’ Libido: What to Know Read More »

GLP-1s in Older Adults: Benefits and Risks to Watch

Melissa Warburg September 18, 2025 The potential anti-aging health benefits of GLP-1s are appealing to adults over 65. However, physicians should be aware of the age-related health issues that GLP-1 use could impact. Potential Benefits Studies of older adults using GLP-1s show improved kidney function and cardiovascular health, including better blood flow and a lower risk

GLP-1s in Older Adults: Benefits and Risks to Watch Read More »

GLP-1 Drugs Linked to Lowered Fracture Risk in Patients With Type 2 Diabetes

SEATTLE — Use of GLP-1 receptor agonists (GLP-1s) was associated with a reduction in fragility fractures among older women with type 2 diabetes (T2D) in a retrospective analysis of data from a global health network. The results suggest that GLP-1 therapy could contribute to bone health. Previous studies have produced mixed results about GLP-1 therapy and bone

GLP-1 Drugs Linked to Lowered Fracture Risk in Patients With Type 2 Diabetes Read More »

GLP-1 weight-loss drugs pose hidden risks for young women, warn experts

by Flinders University edited by Sadie Harley, reviewed by Andrew Zinin   Credit: Unsplash/CC0 Public Domain Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers. A new study has revealed that most Australian women of reproductive age prescribed GLP-1 receptor agonists—medications increasingly used

GLP-1 weight-loss drugs pose hidden risks for young women, warn experts Read More »

Everything Patients Need to Know About Aging on GLP-1s

Eight percent of US adults older than 65 years have taken a GLP-1 agonist either to lose weight or to treat comorbidities like diabetes and cardiovascular disease. Older adults are drawn to the medications because of the many antiaging benefits — some medical experts have even called them a veritable “fountain of youth.” But both

Everything Patients Need to Know About Aging on GLP-1s Read More »

Everything Patients Need to Know About Aging on GLP-1s

Sara Novak September 03, 2025 Eight percent of US adults older than 65 years have taken a GLP-1 agonist either to lose weight or to treat comorbidities like diabetes and cardiovascular disease. Older adults are drawn to the medications because of the many antiaging benefits — some medical experts have even called them a veritable

Everything Patients Need to Know About Aging on GLP-1s Read More »

patient education – What Your Patients Should Know About Traveling With GLP-1s: Preparation, Storage, Side Effects, Disposal

Your patients may inquire about the protocol regarding how they travel with injection GLP-1 medications, including Ozempic, Wegovy, Mounjaro, or Zepbound. As a primary care doctor, you can assure your patients that they can maintain their wellness goals with these simple directives. Injectable Medications Are Permitted People with diabetes have been permitted to travel with

patient education – What Your Patients Should Know About Traveling With GLP-1s: Preparation, Storage, Side Effects, Disposal Read More »

GLP-1s for Sleep Apnea: What They Can (and Can’t) Do

Hi. I’m Dr Alison Kole, a triple-boarded pulmonary, critical care, and sleep medicine physician and the creator and host of the Sleep Is My Waking Passion podcast. Today I want to speak to you about a critical intersection in medicine, which is obesity and obstructive sleep apnea (aka OSA) and why this topic is especially relevant for those of us in

GLP-1s for Sleep Apnea: What They Can (and Can’t) Do Read More »

Scroll to Top